SE467910B - Lyofiliserad eller faelld kombination cefalosporin-zwitterjon och salt - Google Patents
Lyofiliserad eller faelld kombination cefalosporin-zwitterjon och saltInfo
- Publication number
- SE467910B SE467910B SE8800036A SE8800036A SE467910B SE 467910 B SE467910 B SE 467910B SE 8800036 A SE8800036 A SE 8800036A SE 8800036 A SE8800036 A SE 8800036A SE 467910 B SE467910 B SE 467910B
- Authority
- SE
- Sweden
- Prior art keywords
- zwitterion
- chloride
- antibiotic composition
- molar ratio
- sodium
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
- A61K31/542—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
- A61K31/545—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/02—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Inorganic Chemistry (AREA)
- Dermatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Cephalosporin Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US07/001,945 US4808617A (en) | 1985-12-18 | 1987-01-09 | Lyophilized or precipitated cephalosporin zwitterion and salt combination |
Publications (3)
Publication Number | Publication Date |
---|---|
SE8800036D0 SE8800036D0 (sv) | 1988-01-08 |
SE8800036L SE8800036L (sv) | 1988-07-10 |
SE467910B true SE467910B (sv) | 1992-10-05 |
Family
ID=21698538
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SE8800036A SE467910B (sv) | 1987-01-09 | 1988-01-08 | Lyofiliserad eller faelld kombination cefalosporin-zwitterjon och salt |
Country Status (33)
Country | Link |
---|---|
US (1) | US4808617A (fi) |
JP (1) | JP2568226B2 (fi) |
KR (1) | KR950010154B1 (fi) |
AR (1) | AR243501A1 (fi) |
AT (1) | AT388672B (fi) |
AU (1) | AU606361B2 (fi) |
BE (1) | BE1002114A3 (fi) |
CA (1) | CA1307464C (fi) |
CH (1) | CH676202A5 (fi) |
CS (1) | CS265249B2 (fi) |
CY (1) | CY1679A (fi) |
DD (1) | DD264614A5 (fi) |
DE (1) | DE3740588C2 (fi) |
DK (1) | DK166404B1 (fi) |
ES (1) | ES2008951A6 (fi) |
FI (1) | FI89006C (fi) |
FR (1) | FR2609396B1 (fi) |
GB (1) | GB2199746B (fi) |
GR (1) | GR871860B (fi) |
HK (1) | HK5593A (fi) |
HU (1) | HU199686B (fi) |
IE (1) | IE61238B1 (fi) |
IL (1) | IL84346A (fi) |
IT (1) | IT1215666B (fi) |
LU (1) | LU87102A1 (fi) |
NL (1) | NL193266C (fi) |
OA (1) | OA08796A (fi) |
PT (1) | PT86157B (fi) |
SE (1) | SE467910B (fi) |
SG (1) | SG114792G (fi) |
SU (1) | SU1575942A3 (fi) |
YU (1) | YU46689B (fi) |
ZA (1) | ZA88114B (fi) |
Families Citing this family (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4910301A (en) * | 1985-08-05 | 1990-03-20 | Bristol-Myers Company | Cefepime cephalosporin salts |
CA2011116C (en) * | 1989-03-06 | 1999-11-16 | Murray A. Kaplan | Lyophilized bmy-28142 dihydrochloride for parenteral use |
DE19539574A1 (de) | 1995-10-25 | 1997-04-30 | Boehringer Mannheim Gmbh | Zubereitungen und Verfahren zur Stabilisierung biologischer Materialien mittels Trocknungsverfahren ohne Einfrieren |
WO2005094800A2 (en) * | 2004-03-31 | 2005-10-13 | Lupin Ltd. | A co-precipitated cefepime composition and process for preparation thereof |
WO2006109324A2 (en) * | 2005-04-13 | 2006-10-19 | Lupin Limited | Processes for preparation of amorphous cefepime acid addition salts |
JP5491119B2 (ja) * | 2009-10-02 | 2014-05-14 | 日東電工株式会社 | 薬物含有微粒子を含む医薬組成物およびその製造方法 |
US9320740B2 (en) | 2013-03-15 | 2016-04-26 | Merck Sharp & Dohme Corp. | Ceftolozane-tazobactam pharmaceutical compositions |
US9872906B2 (en) | 2013-03-15 | 2018-01-23 | Merck Sharp & Dohme Corp. | Ceftolozane antibiotic compositions |
KR102226197B1 (ko) | 2013-03-15 | 2021-03-11 | 머크 샤프 앤드 돔 코포레이션 | 세프톨로잔 항균성 조성물 |
WO2015035376A2 (en) | 2013-09-09 | 2015-03-12 | Calixa Therapeutics, Inc. | Treating infections with ceftolozane/tazobactam in subjects having impaired renal function |
US20150094293A1 (en) | 2013-09-27 | 2015-04-02 | Calixa Therapeutics, Inc. | Solid forms of ceftolozane |
WO2016035846A1 (ja) | 2014-09-04 | 2016-03-10 | 塩野義製薬株式会社 | カテコール基を有するセファロスポリン類を含有する製剤 |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3953439A (en) * | 1973-08-01 | 1976-04-27 | Smithkline Corporation | Substituted phenylglycylcephalosporins |
US4029655A (en) * | 1975-04-11 | 1977-06-14 | Eli Lilly And Company | Method of preparing stable sterile crystalline cephalosporins for parenteral administration |
CA1213882A (en) * | 1982-03-04 | 1986-11-12 | Jun Okumura | Cephalosporins |
US4406899A (en) * | 1982-03-04 | 1983-09-27 | Bristol-Myers Company | Cephalosporins |
JPS6045514A (ja) * | 1983-08-22 | 1985-03-12 | Shionogi & Co Ltd | 安定な抗菌性凍結乾燥製剤 |
US4604386A (en) * | 1984-07-09 | 1986-08-05 | Eli Lilly And Company | 3-(alkynylalkyloxy) cephalosporins |
JPS61130223A (ja) * | 1984-11-28 | 1986-06-18 | Shionogi & Co Ltd | 抗菌性凍結乾燥製剤 |
FR2585705B1 (fr) * | 1985-08-05 | 1989-01-13 | Bristol Myers Co | Sels de cephalosporine et compositions injectables |
-
1987
- 1987-01-09 US US07/001,945 patent/US4808617A/en not_active Expired - Lifetime
- 1987-11-02 IL IL84346A patent/IL84346A/xx not_active IP Right Cessation
- 1987-11-03 IE IE297087A patent/IE61238B1/en not_active IP Right Cessation
- 1987-11-03 DK DK577387A patent/DK166404B1/da not_active IP Right Cessation
- 1987-11-04 GB GB8725875A patent/GB2199746B/en not_active Expired - Lifetime
- 1987-11-05 CA CA000551105A patent/CA1307464C/en not_active Expired - Lifetime
- 1987-11-06 AU AU80856/87A patent/AU606361B2/en not_active Expired
- 1987-11-17 KR KR1019870012935A patent/KR950010154B1/ko not_active IP Right Cessation
- 1987-11-17 HU HU875100A patent/HU199686B/hu unknown
- 1987-11-18 PT PT86157A patent/PT86157B/pt unknown
- 1987-11-19 FI FI875122A patent/FI89006C/fi not_active IP Right Cessation
- 1987-11-20 JP JP62293855A patent/JP2568226B2/ja not_active Expired - Lifetime
- 1987-11-25 FR FR878716339A patent/FR2609396B1/fr not_active Expired - Lifetime
- 1987-11-30 DE DE3740588A patent/DE3740588C2/de not_active Expired - Lifetime
- 1987-12-08 GR GR871860A patent/GR871860B/el unknown
- 1987-12-10 DD DD87310253A patent/DD264614A5/de unknown
- 1987-12-23 AT AT0341687A patent/AT388672B/de not_active IP Right Cessation
-
1988
- 1988-01-06 CS CS88158A patent/CS265249B2/cs not_active IP Right Cessation
- 1988-01-07 YU YU2388A patent/YU46689B/sh unknown
- 1988-01-07 IT IT8819013A patent/IT1215666B/it active
- 1988-01-07 NL NL8800025A patent/NL193266C/nl not_active IP Right Cessation
- 1988-01-08 SU SU884355050A patent/SU1575942A3/ru active
- 1988-01-08 ES ES8800035A patent/ES2008951A6/es not_active Expired
- 1988-01-08 OA OA59260A patent/OA08796A/xx unknown
- 1988-01-08 BE BE8800015A patent/BE1002114A3/fr not_active IP Right Cessation
- 1988-01-08 ZA ZA88114A patent/ZA88114B/xx unknown
- 1988-01-08 LU LU87102A patent/LU87102A1/fr unknown
- 1988-01-08 SE SE8800036A patent/SE467910B/sv not_active IP Right Cessation
- 1988-01-08 AR AR88309804A patent/AR243501A1/es active
- 1988-01-11 CH CH68/88A patent/CH676202A5/de not_active IP Right Cessation
-
1992
- 1992-11-02 SG SG1147/92A patent/SG114792G/en unknown
-
1993
- 1993-01-28 HK HK55/93A patent/HK5593A/xx not_active IP Right Cessation
- 1993-10-10 CY CY1679A patent/CY1679A/xx unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
SE467910B (sv) | Lyofiliserad eller faelld kombination cefalosporin-zwitterjon och salt | |
US3801633A (en) | N-substituted amino acids having antiviral effects | |
NL192266C (nl) | Werkwijze voor het bereiden van een kristallijn cefepime-dihydrochloride alsmede het kristallijne dihydrochloride en mengsels die het bevatten. | |
IE861984L (en) | Crystalline salt of guanine derivative | |
KR101455208B1 (ko) | 안정적인 s-아데노실메티오닌의 염 및 이를 제조하기 위한 방법 | |
JPH045038B2 (fi) | ||
DK163032B (da) | Lyofiliseret antibakterielt praeparat indeholdende 7beta-difluormethylthioacetamido-7alfa-methoxy-3-oe1-(2-hydroxyalkyl)-1h-tetrazol-5-ylaa-thiomethyl-1-dethia-1-oxa-3-cephem-4-carboxylsyrealkalimetalsalt samt fremgangsmaade til fremstilling af praeparatet | |
KR20170032348A (ko) | 저 치환된 폴리믹신 및 이의 조성물 | |
CA1134269A (en) | Synergistic mixtures | |
CA2011116C (en) | Lyophilized bmy-28142 dihydrochloride for parenteral use | |
US3205137A (en) | Bacitracin derivatives | |
JPS58103392A (ja) | 3位においてチオメチルヘテロ環基により置換されたセフアロスポリンの新規な誘導体、これら化合物の製造方法およびこれらを含有する薬学的組成物 | |
CA1307206C (en) | Antibacterial agent for mammal use comprising cephalosporin derivatives as an effective ingredient | |
EP0351795A2 (en) | Novel deoxyadenosine compounds and methods of making and using the same | |
US3531460A (en) | Erythromycin tetracycline containing antibiotic derivatives | |
KR800000604B1 (ko) | 비경구용 0-포밀세파만돌 나트륨염제제의 제조방법 | |
PL87238B1 (fi) | ||
JPH0150235B2 (fi) | ||
JPS6310158B2 (fi) | ||
JPH05178743A (ja) | エイズウイルス感染阻害剤 | |
DE2013926A1 (en) | Chloramphenicol and thiamphenicol esters | |
JPH0443074B2 (fi) |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
NAL | Patent in force |
Ref document number: 8800036-9 Format of ref document f/p: F |
|
NUG | Patent has lapsed |